EP Patent

EP2887923A4 — OPHTHALMIC FORMULATION OF FATTY ACID OR LIPID OF POLYOXYL AND TREATMENT OF OCULAR PATHOLOGIES

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2016-03-30 · 10y expired

What this patent protects

Patent listed against Sandimmune.

Drugs covered by this patent

Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)

Patent Metadata

Patent number: EP2887923A4
Jurisdiction: EP
Classification: —
Expires: 2016-03-30
Drug substance claim: No
Drug product claim: No
Assignee: Sun Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.